Engineers Gate Manager LP Bicycle Therapeutics PLC Transaction History

Engineers Gate Manager LP

  • $4.86 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$19.9 - $26.25 $319,912 - $421,995
16,076 New
16,076 $322,000
Q2 2022

Aug 15, 2022
SELL
$12.95 - $46.99 $100,621 - $365,112
-7,770 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$40.12 - $59.5 $311,732 - $462,315
7,770 New
7,770 $341,000

Others Institutions Holding BCYC

# of Institutions
111
Shares Held
40.8M
Call Options Held
39.6K
Put Options Held
24.6K
View Full List

About BICYCLE THERAPEUTICS plc

BCYC Quotes by TradingView
  • Ticker BCYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,676,100
  • Market Cap $436M
  • Description
  • Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...
More about BCYC
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email